Brain diffusion-weighted imaging in diabetic patients with retinopathy

European Review for Medical and Pharmacological Sciences

Volumn 16, Issue 1, 2012, Pages 126-131

  Dogan, M ^a   Ozsoy, E ^a   Doganay, S ^a   Burulday, V ^a   Firat, P G ^a   Ozer, A ^a   Alkan, A ^b  

^a INONU UNIVERSITY   (Turkey)

^b BEZMIALEM VAKIF UNIVERSITY   (Turkey)

Author keywords

ADC; Diabetic retinopathy; Diffusion weighted imaging; Visual center

Indexed keywords

HEMOGLOBIN A1C;

ADULT; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONA RADIATA (BRAIN); DIABETIC PATIENT; DIABETIC RETINOPATHY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DORSOLATERAL FRONTAL CORTEX; DORSOMEDIAL FRONTAL CORTEX; FEMALE; FRONTAL CORTEX; HUMAN; MALE; NONPROLIFERATIVE DIABETIC RETINOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBITAL CORTEX; RETINOPATHY; REVIEW; THALAMUS; VISUAL CORTEX;

AGED; AGING; ANALYSIS OF VARIANCE; BRAIN; DIABETES MELLITUS; DIABETIC RETINOPATHY; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FRONTAL LOBE; GYRUS CINGULI; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SEX CHARACTERISTICS; VISUAL CORTEX;

EID: 84859851062     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. BIESSELS GJ, KAPPELLE AC, BRAVENBOER B, ERKELENS DW, GISPEN WH. Cerebral function in diabetes mellitus. Diabetologia 1994;37:643-650. (Pubitemid 24210219)
2. BRANDS AM, HENSELMANS JM, HAAN EH, BIESSELS GJ. Diabetic encephalopathy: An underexposed complication of diabetes mellitus. Nederlands Tijdschrift voor Geneeskunde 2003;147:11-14. (Pubitemid 36055196)
3. TIEHUIS A, MEER F, MALI W, PLEIZIER M, BIESSELS GJ, KAPPELLE LJ, LUIJTEN P. MR spectroscopy of cerebral white matter in type 2 diabetes; no association with clinical variables and cognitive performance. Neuroradiology 2010;52:155-161.
4. BRANDS AM, KESSELS R P, DE HAAN EH, KAPPELLE LJ, BIESSELS GJ. Cerebral dysfunction in type 1 diabetes: effects of insulin, vascular risk factors and blood-glucose levels. Eur J Pharmacol 2004;490:159-168. (Pubitemid 38482169)
5. BIESSELS GJ, VAN DER HEIDE L P, KAMAL A, BLEYS RL, GISPEN WH. Ageing and diabetes: implications for brain function. Eur J Pharmacol 2002;441:1-14. (Pubitemid 34465684)
6. RYAN CM, GECKLE MO, ORCHARD TJ. Cognitive efficiency declines over time in adults with Type 1 diabetes: effects of micro-and macrovascular complications. Diabetologia 2003;46:940-948 (Pubitemid 36961317)
7. WESSELS AM, SIMSEK S, REMIJNSE PL, VELTMAN DJ, BIESSELS GJ, BARKHOF F, SCHELTENS P, SNOEK FJ, HEINE RJ, ROMBOUTS SA. Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy. Diabetologia 2006;49:2474-2480. (Pubitemid 44359110)
8. LE BILHAN D. Diffusion and perfusion magnetic resonance imaging: Applications to functional MRI. New York: Raven Press; 1995, pp. 8-33.
9. BAYSAL T, DOGAN M, KARLIDAG R, OZISIK HI, BAYSAL O, BULUT T, SARAC K. Diffusion-weighted imaging in chronic Behçet patients with and without neurological findings. Neuroradiology 2005;47:431-437. (Pubitemid 41038860)
10. HAJNAL J V, DORAN M, HALL AS, COLLINS AG, QATRIDGE A, PENNOCK JM, YOUNG IR, BYDDER GM. MR imaging of anisotropically restricted diffusion of water in the nervous system: technical, anatomic, and pathologic considerations. J Comput Assist Tomogr 1991;15:1-18.
11. PROVANZALE JM, SORENSEN GA. Diffusion-weighted MR imaging in acute stroke: theoretic considerations and clinical applications. Am J Roentgenol 1999;173:1467-1469.
12. SORENSEN GA, COPEN WA, DAWIS TL. Human acute cerebral ischemia: detection of changes in water diffusion anisotropy by using MR imaging. Radiology 1999;212:785-792. (Pubitemid 29410983)
13. WESSELS AM, ROMBOUTS SA, SIMSEK S, KUIJER J P, KOSTENSE PJ, BARKHOF F, SCHELTENS P, SNOEK FJ, HEINE RJ. Microvascular disease in type 1 diabetes alters brain activation: a functional magnetic resonance imaging study. Diabetes 2006;55:334-340. (Pubitemid 43343261)
14. ALKAN A, SAHIN I, KESKIN L, CIKIM AS, KARAKAS HM, SIGIRCI A, ERDEM G. Diffusion-weighted imaging features of brain in obesity. Magn Reson Imaging 2008;26:446-450. (Pubitemid 351508341)
15. MORITANI T, SHRIER DA, NUMAGUCHI Y, TAKASE Y, TAKAHASHI C, WANG HZ, SHIBATA DK, ABE T, UKISU R, OHGIYA Y, TSUCHIYA A, KUSHIHASHI T, GOKAN T, MUNECHIKA H. Diffusion-weighted echo-planar MR imaging: clinical applications and pitfalls, a pictorial essay. Clin Imaging 2000;24:181-192. (Pubitemid 32220077)
16. BAYSAL T, BULUT T, GÖKIRMAK M, KALKAN S, DUSAK A, DOGAN M. Diffusion-weighted MR imaging of pleural fluid: differentiation of transudative vs exudative pleural effusions. Eur Radiol 2004;14:890-896. (Pubitemid 38678912)
17. RESKE-NIELSEN E, LUNDBAEK K, RAFAELSEN OJ. Pathological changes in the central and peripheral nervous system of young longterm diabetics. Diabetologia 1965;1:233-241.
18. BIESSELS GJ, VAN DER HEIDE L P, KAMAL A, BLEYS RL, GISPEN WH. Ageing and diabetes: implications for brain function. Eur J Pharmacol 2002;441:1-14. (Pubitemid 34465684)
19. HAKYEMEZ B, ERDOGAN C, YILDIZ H, ERCAN I, PARLAK M. Apparent diffusion coefficient measurements in the hippocampus and amygdala of patients with temporal lobe seizures and in healthy volunteers. Epilepsy Behav 2005;6:250-256. (Pubitemid 40247161)
20. SARAC K, AKINCI A, ALKAN A, ASLAN M, BAYSAL T, ÖZCAN C. Brain metabolite changes on proton magnetic resonance spectroscopy in children with poorly controlled type 1 diabetes mellitus. Neuroradiology 2005;47:562-565. (Pubitemid 41086414)
21. SAHIN I, ALKAN A, KESKIN L, CIKIM A, KARAKAS HM, FIRAT AK, SIGIRCI A. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus. J Diabetes Its Complic 2008;22:254-260. (Pubitemid 351885485)
22. BARBER AJ, LIETH E, KHIN SA, ANTONETTI DA, BUCHANAN AG, GARDNER TW. Neural apoptosis in the retina during experimental and human diabetes: Early onset and effect of insulin. J Clin Invest 1998;102:783-791. (Pubitemid 28399611)
23. MIZUTANI M, GERHARDINGER C, LORENZI M. Muller cell changes in human diabetic retinopathy. Diabetes 1998;47:445-449. (Pubitemid 28104208)
24. NAKAMURA M, BARBER AJ, ANTONETTI DA, LANOUE K F, ROBINSON KA, BUSE MG, GARDNER TW. Excessive hexosamines block the neuroprotective effect of insulin and induce apoptosis in retinal neurons. J Biol Chem 2001;276:43748-43755.
25. KRADY JK, BASU A, ALLEN CM, XU Y, LANOUE K F, GARDNER TW, LEVISON SW. Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 2005;54:1559-1565. (Pubitemid 40586690)
26. SIMONSEN SE. The value of the oscillatory potential in selecting juvenile diabetics at risk of developing proliferative retinopathy. Acta Ophthalmol (Copenh) 1980;58:865-878. (Pubitemid 11209558)
27. BOUCARD CC, HERNOWO AT, MAGUIRE R P, JANSONIUS NM, ROERDINK JB, HOOYMANS JM, CORNELISSEN FW. Changes in cortical grey matter density associated with long-standing retinal visual field defects. Brain 2009:132; 1898-1906.